Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Akers Biosciences Inc. (NASDAQ: AKER).

Full DD Report for AKER

You must become a subscriber to view this report.


Recent News from (NASDAQ: AKER)

Market Trends Toward New Normal in Addus HomeCare, Sandstorm Gold, BioSpecifics Technologies, Itau Unibanco Holding S.A, Akers Biosciences, and Kosmos Energy - Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Addus HomeCare Corporation (NASDAQ:ADUS), Sandstorm Gold Ltd (NYSE:SAND),...
Source: GlobeNewswire
Date: August, 21 2018 08:20
Akers Biosciences Announces Q2 and H1 2018 Earnings
THOROFARE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, reports its financial results for the three months and six months ended June 30, 2018. ...
Source: GlobeNewswire
Date: August, 14 2018 16:17
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 13, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER ) for violations of §§10(b) a...
Source: ACCESSWIRE IA
Date: August, 13 2018 12:05
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline: August 13, 2018
NEW YORK, NY / ACCESSWIRE / August 13, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) and certain of its officers, on behalf of shareholders who purchased or...
Source: ACCESSWIRE IA
Date: August, 13 2018 10:21
DEADLINE MONDAY: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 12, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER ) for violations of §§10(b) a...
Source: ACCESSWIRE IA
Date: August, 12 2018 21:40
AKER AUG 13 DEADLINE: Rosen Law Firm Reminds Akers Biosciences, Inc. Investors of Important Deadline in First Filed Case - AKER
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akers Biosciences, Inc. (NASDAQ:AKER) from May 15, 2017 through June 5, 2018 (the “Class Period”) of the important August 13, 2018 lead plaintiff deadline in the first filed suit commence...
Source: Business Wire
Date: August, 12 2018 11:00
ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
NEW YORK, NY / ACCESSWIRE / August 11, 2018 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the "Class Period"). The lawsuit seeks to recove...
Source: ACCESSWIRE IA
Date: August, 11 2018 09:00
The Law Offices of Howard G. Smith Reminds Investors of August 13th Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER)
Law Offices of Howard G. Smith reminds investors of the  August 13, 2018  deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ: AKER...
Source: Business Wire
Date: August, 10 2018 19:42
AUGUST 13 DEADLINE: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 10, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER ) for violations of §§10(b) a...
Source: ACCESSWIRE IA
Date: August, 10 2018 12:50
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PG&E, Akers Biosciences, and UNUM and Encourages Investors to Contact the Firm
NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of PG&E Corporation, Akers Biosciences, Inc., and UNUM Group.  Stockholders have until the deadlines listed below t...
Source: GlobeNewswire
Date: August, 09 2018 18:06

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-111.291.241.32921.24145,686
2018-12-101.301.311.341.23189,506
2018-12-071.501.34191.501.30209,230
2018-12-061.361.33671.361.2608168,450
2018-12-051.431.311.431.23368,674

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1111,53035,38632.5835Cover
2018-12-1028,36570,60240.1759Short
2018-12-0729,60060,66448.7934Short
2018-12-0613,52739,24034.4725Cover
2018-12-0467,905120,72456.2481Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AKER.


About Akers Biosciences Inc. (NASDAQ: AKER)

Logo for Akers Biosciences Inc. (NASDAQ: AKER)

Not available

 

 

 

Current Management

  • Thomas A. Nicolette / CEO, President

Current Share Structure

  • Market Cap: $4,352,052 - 05/14/2018
  • Authorized: 500,000,000 - 11/01/2017
  • Issue and Outstanding: 9,936,191 - 11/01/2017

 


Recent Filings from (NASDAQ: AKER)

Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: May, 16 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: May, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: April, 10 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: April, 10 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: April, 03 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 03 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 13 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 01 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 18 2018

 

 


Daily Technical Chart for (NASDAQ: AKER)

Daily Technical Chart for (NASDAQ: AKER)


Stay tuned for daily updates and more on (NASDAQ: AKER)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: AKER)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AKER is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AKER and does not buy, sell, or trade any shares of AKER. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/